MRNA vs SYK · rev $145.0M vs P/E 35, rev $6.59B
Moderna Inc (MRNA) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
MRNA currently screens at market cap $24.52B. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the MRNA and SYK stock pages for the full models.
Not investment advice.